RA CAPITAL MANAGEMENT, L.P. - 06 Mar 2025 SCHEDULE 13D/A Report for JANUX THERAPEUTICS, INC. Common Stock, par value $0.001 per share (JANX)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
JANUX THERAPEUTICS, INC. Common Stock, par value $0.001 per share
Symbol
JANX
Shares outstanding
60,157,673 shares
Disclosed Ownership
11,971,377 shares
Ownership
20%
Form type
SCHEDULE 13D/A
Filing time
10 Mar 2025, 16:33:42 UTC
Date of event
06 Mar 2025
SEC
View on sec.gov

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 20% ownership in JANUX THERAPEUTICS, INC. Common Stock, par value $0.001 per share (JANX) on 06 Mar 2025."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A for JANUX THERAPEUTICS, INC. Common Stock, par value $0.001 per share (JANX).
  • Disclosed ownership: 20%.
  • Date of event: 06 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Mar 2025, 16:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 20% 11,971,377 0 11,971,377 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory 0001346824
Peter Kolchinsky 20% 11,971,377 0 11,971,377 /s/ Peter Kolchinsky Peter Kolchinsky 0001384859
Rajeev Shah 20% 11,971,377 0 11,971,377 /s/ Rajeev Shah Rajeev Shah 0001619841
RA Capital Healthcare Fund, L.P. 18% 10,861,013 0 10,861,013 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager 0001315082